Anti-B7-H3 (Research Grade Enoblituzumab Biosimilar) sinobiological 68202-H001
| Catalog No. | Size | Price (USD) |
| 68202-H001-5 | 5 mg | $740.55 |
| 68202-H001-25 | 25 mg | $2,221.66 |
| 68202-H001-500 | 500 µg | $222.17 |
| Catalog No. | Size | Price (USD) |
| 68202-H001-5 | 5 mg | $740.55 |
| 68202-H001-25 | 25 mg | $2,221.66 |
| 68202-H001-500 | 500 µg | $222.17 |
General Information
| Product name | Anti-B7-H3 (Research Grade Enoblituzumab Biosimilar) |
| Species reactivity | Reacts with: Human |
| Specificity | B7-H3 |
| Preparation | This product is a recombinant monoclonal antibody expressed from HEK293 cells. |
| Source | IgG1, Kappa |
| Purification | Protein A |
| Formulation | Histidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0 |
| Conjugate | Unconjugated |
| Endotoxin | ≦ 1 EU/mg |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
title: A monoclonal antibody targeting B7-H3 in human embryonic stem cells exhibits anti-tumor activity in hepatocellular carcinoma xenografts
authors: San Ha Han; Hyosun Seo; ...; Chun Jeih Ryu
journal: Translational Oncology
date: 2026-02-01
pmid: 41389673
cited_by_count: 0
techniques: ADCC Assay; Biomarker Discovery; Blocking Assay; Concentration Assay; Control; Immunoprecipitation; Injection; Isolation; Lysis; Membrane; Over Expression; Saline; Western Blot
bioz_score: 94
title: Improving Targeted Delivery and Antitumor Efficacy of TRAIL through Fusion with a B7H3-Antagonistic Affibody.
authors: Xiaomeng Lu; Xinyu Zhan; ...; Dianlong Jia
journal: Molecular Pharmaceutics
date: 2024-12-02
pmid: 39620978
doi: 10.1021/acs.molpharmaceut.4c00891
cited_by_count: 0
techniques: Expressing; Flow Cytometry; Fluorescence; Lysis; Microscopy; Staining; Western Blot
bioz_score: 94
title: Development of a Human B7-H3-Specific Antibody with Activity against Colorectal Cancer Cells through a Synthetic Nanobody Library
authors: Jingxian Li; Bingjie Zhou; ...; Ali Zarrabi
journal: Bioengineering
date: 2024-04-15
pmid: 38671802
doi: 10.3390/bioengineering11040381
pmcid: 11047927
cited_by_count: 6
techniques: Bicinchoninic Acid Protein Assay; Expressing; Incubation; Knockdown; Membrane
bioz_score: 94
title: B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vivo.
authors: Qian Zhang; Zhiqiang Zhang; ...; Ziming Zhang
journal: BMC Cancer
date: 2022-11-03
pmid: 36320072
doi: 10.1186/s12885-022-10229-8
cited_by_count: 25
techniques: Immunohistochemistry; Immunostaining; Labeling; Microscopy; Staining
bioz_score: 93
title: B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vitro
authors: Qian Zhang; Zhiqiang Zhang; ...; Ziming Zhang
journal: Europe PMC
date: 2022-04-26
doi: 10.21203/rs.3.rs-1570552
cited_by_count: 0
techniques: Immunostaining; Labeling; Microscopy; Staining
bioz_score: 94
title: Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
authors: Jenny Mattsson; Ludvig Ekdahl; ...; Björn Nilsson
journal: Nature Communications
date: 2021-02-24
pmid: 33627649
doi: 10.1038/s41467-021-21518-4
pmcid: 7904777
cited_by_count: 3
techniques: Blocking Assay; Flow Cytometry
bioz_score: 94
MDSD